Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial (vol 16, pg 31, 2016)

被引：0
|
作者：
Tapia, M. D.
Sow, S. O.
Lyke, K. E.
机构：
来源：
LANCET INFECTIOUS DISEASES | 2016年 / 16卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：16 / 16
页数：1
相关论文
共 50 条
  • [41] Safety and immunogenicity of the novel tuberculosis vaccine ID93+GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial
    Penn-Nicholson, Adam
    Tameris, Michele
    Smit, Erica
    Day, Tracey A.
    Musvosvi, Munyaradzi
    Jayashankar, Lakshmi
    Vergara, Julie
    Mabwe, Simbarashe
    Bilek, Nicole
    Geldenhuys, Hendrik
    Luabeya, Angelique Kany-Kany
    Ellis, Ruth
    Ginsberg, Ann M.
    Hanekom, Willem A.
    Reed, Steven G.
    Coler, Rhea N.
    Scriba, Thomas J.
    Hatherill, Mark
    LANCET RESPIRATORY MEDICINE, 2018, 6 (04): : 287 - 298
  • [42] Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial
    Richmond, Peter
    Hatchuel, Lara
    Dong, Min
    Ma, Brenda
    Hu, Branda
    Smolenov, Igor
    Li, Ping
    Liang, Peng
    Han, Htay Htay
    Liang, Joshua
    Clemens, Ralf
    LANCET, 2021, 397 (10275): : 682 - 694
  • [43] Safety, immunogenicity, and optimal dosing of a modified vaccinia Ankara-based vaccine against MERS-CoV in healthy adults: a phase 1b, double-blind, randomised placebo- controlled clinical trial
    Raadsen, Matthijs P.
    Dahlke, Christine
    Fathi, Anahita
    Hardtke, Svenja
    Kluever, Michael
    Kraehling, Verena
    Gerresheim, Gesche K.
    Mayer, Leonie
    Mykytyn, Anna Z.
    Weskamm, Leonie M.
    Zoran, Tamara
    van Gorp, Eric C. M.
    Sutter, Gerd
    Becker, Stephan
    Haagmans, Bart L.
    Addo, Marylyn M.
    LANCET INFECTIOUS DISEASES, 2025, 25 (02): : 231 - 242
  • [44] Safety and efficacy of the sodium-glucose cotransporter 1 inhibitor mizagliflozin for functional constipation: a randomised, placebo-controlled, double-blind phase 2 trial (vol 3, pg 603, 2018)
    Fukudo, S.
    Endo, Y.
    Hongo, M.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (09): : E4 - E4
  • [45] a phase 1 clinical trial of therapeutic vaccine t101 in chronic hepatitis b (chb) patients: a randomized, double-blind, placebo-controlled, single and multiple injections, dose escalation study
    Hu, Yue
    Wang, Xiaomin
    Wang, Zhiming
    Gao, Dong
    Zhang, Lan
    Wu, Min
    Zhang, Hong
    Hu, Zhongyu
    Qiu, Shaohui
    Chen, Hong
    Wang, Meng
    Li, Xiaojiao
    Ding, Yanhua
    Niu, Junqi
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E153 - E154
  • [46] Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial (vol 376, pg 595, 2010)
    Greenway, F. L.
    Fujioka, K.
    Plodkowski, R. A.
    LANCET, 2010, 376 (9741): : 594 - 594
  • [47] Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial (vol 376, pg 595, 2010)
    Greenway, F. L.
    Fujioka, K.
    Plodkowski, R. A.
    LANCET, 2010, 376 (9750): : 1392 - 1392
  • [48] Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
    Zhang, Yanjun
    Zeng, Gang
    Pan, Hongxing
    Li, Changgui
    Hu, Yaling
    Chu, Kai
    Han, Weixiao
    Chen, Zhen
    Tang, Rong
    Yin, Weidong
    Chen, Xin
    Hu, Yuansheng
    Liu, Xiaoyong
    Jiang, Congbing
    Li, Jingxin
    Yang, Minnan
    Song, Yan
    Wang, Xiangxi
    Gao, Qiang
    Zhu, Fengcai
    LANCET INFECTIOUS DISEASES, 2021, 21 (02): : 181 - 192
  • [49] Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
    Wu, Zhiwei
    Hu, Yaling
    Xu, Miao
    Chen, Zhen
    Yang, Wanqi
    Jiang, Zhiwei
    Li, Minjie
    Jin, Hui
    Cui, Guoliang
    Chen, Panpan
    Wang, Lei
    Zhao, Guoqing
    Ding, Yuzhu
    Zhao, Yuliang
    Yin, Weidong
    LANCET INFECTIOUS DISEASES, 2021, 21 (06): : 803 - 812
  • [50] Repair of acute respiratory distress syndrome by stromal cell administration (REALIST): a structured study protocol for an open-label dose-escalation phase 1 trial followed by a randomised, triple-blind, allocation concealed, placebo-controlled phase 2 trial
    Ellen Gorman
    Manu Shankar-Hari
    Phil Hopkins
    William S. Tunnicliffe
    Gavin D. Perkins
    Jonathan Silversides
    Peter McGuigan
    Colette Jackson
    Roisin Boyle
    Jamie McFerran
    Cliona McDowell
    Christina Campbell
    Margaret McFarland
    Jon Smythe
    Jacqui Thompson
    Barry Williams
    Gerard Curley
    John G. Laffey
    Mike Clarke
    Daniel F. McAuley
    Cecilia O’Kane
    Trials, 23
12345